Patent attributes
The invention relates to an implant for reducing ocular hypertension. Said implant can be used in particular to prevent and treat glaucomas that are emerging or occur. In particular, the implant is an implant (10) for the Schlemm's canal, which comprises a bridge (20), which has a first end point (22) and a second end point (24) and a first support region (26), a second support region (28), and a connecting piece (30), the bridge (20) extending along a first line (L1) from the first end point (22) to the second end point (24) across the first support region (26), the connecting piece (30), and the second support region (28) and the connecting piece (30) having a first cross-sectional area on average along the first line (L1) and the first support region (26) having a second cross-sectional area on average along the first line (L1) after the implantation, characterized in that the second cross-sectional area is at least 50% larger than the first cross-sectional area.
